08/14/2025 8:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) Landon Kristen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/14/2025 8:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) Landon Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2025 8:24 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) Landon Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2025 1:45 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/18/2025 4:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
07/18/2025 3:57 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2025 3:57 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Orca Capital AG (Filed by)
| Form SCHEDULE 13G | |
07/17/2025 3:59 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Orca Capital AG (Filed by)
| Form SCHEDULE 13G/A | |
07/16/2025 7:49 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B4 | |
07/15/2025 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
07/07/2025 4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for SXTPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
06/09/2025 4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2025 7:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 2:10 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 1:57 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Ayrton Capital LLC (Filed by)
| Form SCHEDULE 13G | |
04/09/2025 7:31 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2025 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
02/14/2025 4:21 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025 4:23 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/11/2025 3:53 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
02/06/2025 9:04 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
02/03/2025 3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
01/30/2025 4:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2025 7:28 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 424B5 | |
01/24/2025 3:51 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) MILLER TYRONE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2025 3:52 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 3:58 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) MILLER TYRONE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2025 4:00 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2025 3:05 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:35 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 4:07 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:14 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 12:44 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 3:01 PM | 60 DEGREES PHARMACEUTICALS, INC. (Subject) 60 Degrees Pharmaceuticals (Subject) Knight Therapeutics Inc (Filed by)
| Form SC 13G/A | |
11/06/2024 4:26 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 2:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form DEF 14A | |
10/08/2024 7:17 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2024 9:56 AM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form PRE 14A | |
09/30/2024 11:15 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form EFFECT | |
09/19/2024 3:30 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
09/11/2024 3:46 PM | 60 DEGREES PHARMACEUTICALS, INC. (Issuer) 60 Degrees Pharmaceuticals (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
08/28/2024 2:59 PM | 60 DEGREES PHARMACEUTICALS, INC. (Filer) 60 Degrees Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |